Products and Pricing

Corporate Reputation of Pharma Publications – 2025

The annual Corporate Reputation of Pharma report is based on the feedback of over 2500+ patient groups worldwide. This report provides invaluable insights into how pharma companies are perceived (and ranked) by patient groups and how they can improve.

 

The complete package is delivered as 22 reports. All reports are available on a global licence, which can be circulated to all of a company’s full-time employees:

 

 

11 geographic areas

  • Global
  • ANZ
  • Canada
  • China
  • France
  • Germany
  • Italy
  • Japan
  • Spain
  • UK
  • USA
 11 therapy areas

  • Bleeding disorders
  • Cancer: all types
  • Cancer: blood
  • Cancer: breast
  • Cancer: lung
  • Cancer: prostate
  • Diabetes
  • Multiple sclerosis
  • Neurology
  • Neurodegenerative diseases
  • Rare diseases

Supplementary reports, products, and services

  • Bespoke PowerPoint decks: Any, or all, of the 22 off-the-shelf reports—with the data bespoke tailored to your company, presented in the form of a PowerPoint.
  • Moving Forward’ series of dashboards: Focuses on the feedback received from patient groups, listing their priorities for pharma, based on the set of ten indicators of corporate reputation. Delivered as a user-friendly online dashboard, using unbiased and robust data. The dashboard lets you mine navigate, sort and export what matters most to the patient groups in the target therapy areas and markets of interest to your company. The data are generated in seconds. There are two versions of Moving Forward: (1) global and therapy-wide data (2) feedback from just your company’s patient-group partners.
  • Bespoke reports: Additional analyses of the ‘Corporate Reputation of Pharma’ dataset, on request—with the data bespoke tailored to your company.
  • Sharing reports with 3rd parties: PatientView holds the copyright of the data contained in all of its reports/PowerPoints. If your company wishes to share the reports with a 3rd party (such as an agency), you can do so on request, at an extra cost.

All prices in £ Sterling/GBP

SINGLE REPORT
8,500

Additional reports cost an extra £1,500 per report:

 

  • PowerPoint decks – GBP 2,000 per report
  • ‘Moving Forward’
      1. Global and therapy-wide dashboard: £10,000;
      2. Feedback from your company’s patient-group partners: £20,000
  • Bespoke reports – GBP 8,500 per dataset
  • Sharing with 3rd parties – GBP 1,000 per report

 

 

Additional separate dashboards not included in the Corporate Reputation series:

 

Contact PatientView for more information by using the form below:

     

    Why PatientView?

    • Knowledge of the patient movement
    • Researching patient groups since 2000
    • Permission-based database of 40,000 patient groups worldwide
    • Surveys conducted in 20 languages

    Why Patient Groups?

    • Experts in patients’ concerns across multiple disease areas
    • Knowledge of patients’ issues at a country/local level
    • Knowledge of pharmaceutical-industry issues and challenges
    • Advocates for better healthcare
    • Instrumental in shaping care and raising awareness
    • Strong governance and ethics, reliable data

     

    Explore more of PatientView’s research.

    Up